All Comments by
- Michael G. Agadjanyan on Intracerebroventricular amyloid-beta antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice.
- Terrence Town on Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques.
- Suzanne Guenette on Keystone: Death Receptor Ligand—New Role for APP, New Model for AD? PAPER RETRACTED.
- George Martin on The Rodent in Old Age
- Gang Liu on Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis.
- Sanjay Pimplikar on Keystone: Death Receptor Ligand—New Role for APP, New Model for AD? PAPER RETRACTED.
- David Cribbs on Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques.
- Lon S. Schneider on Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study.
- Grace Stutzmann on Calcium signaling and neurodegenerative diseases.
- Lary Walker on Driving amyloid toxicity in a yeast model by structural changes: a molecular approach.
- Takaomi Saido on Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.
- Jeffrey D. Rothstein on New Gene for ALS: RNA Regulation May Be Common Culprit
- Andrea Fuso on Epigenetic changes in Alzheimer's disease: decrements in DNA methylation.
- Mary Reid on Keystone: Death Receptor Ligand—New Role for APP, New Model for AD? PAPER RETRACTED.
- Chad Dickey on Garbage BAG2 Takes Out the Tau